Search research articles
Contact Us
Filters
Showing results (351-360 of 423) with videos related to
Page
of 43
Sort By:
Molecular Cancer Therapeutics
|
February 3, 2016
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib
James P De Andrade, Jung M Park, Vivian W Gu, et al.
Pediatric Blood & Cancer
|
April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Meredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Blood
|
September 3, 2009
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Qing Zhou, Christoph Bucher, Meghan E Munger, et al.
Oncogene
|
March 17, 2015
The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis
J M Park, T Wu, A R Cyr, et al.
Journal of Dairy Science
|
July 20, 2023
Effect of reproductive management programs that prioritized artificial insemination at detected estrus or timed artificial insemination on the reproductive performance of primiparous Holstein cows of different genetic merit for fertility
E M Sitko, M M Perez, G E Granados, et al.
Pediatric Blood & Cancer
|
August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)
Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Cancer
|
October 10, 2025
5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue sarcomas: Results from a prospective trial
Edward Y Cheng, Andrea P Espejo Freire, Juan C Manivel, et al.
Cancer Research
|
June 3, 2004
A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells
Martin G Sauer, Marna E Ericson, Brenda J Weigel, et al.
Pediatric Blood & Cancer
|
August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Page
of 43
Search research articles
Search
Showing results (351-360 of 423) with videos related to
Sort By:
Page
of 43
Molecular Cancer Therapeutics
|
February 3, 2016
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib
James P De Andrade, Jung M Park, Vivian W Gu, et al.
Pediatric Blood & Cancer
|
April 26, 2018
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Meredith K Chuk, Brigitte C Widemann, Charles G Minard, et al.
Blood
|
September 3, 2009
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Qing Zhou, Christoph Bucher, Meghan E Munger, et al.
Oncogene
|
March 17, 2015
The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis
J M Park, T Wu, A R Cyr, et al.
Journal of Dairy Science
|
July 20, 2023
Effect of reproductive management programs that prioritized artificial insemination at detected estrus or timed artificial insemination on the reproductive performance of primiparous Holstein cows of different genetic merit for fertility
E M Sitko, M M Perez, G E Granados, et al.
Pediatric Blood & Cancer
|
August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)
Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.
Cancer
|
October 10, 2025
5-fluoro-deoxyglucose PET/CT response after neoadjuvant chemotherapy predicts long-term outcomes in soft tissue sarcomas: Results from a prospective trial
Edward Y Cheng, Andrea P Espejo Freire, Juan C Manivel, et al.
Cancer Research
|
June 3, 2004
A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells
Martin G Sauer, Marna E Ericson, Brenda J Weigel, et al.
Pediatric Blood & Cancer
|
August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Page
of 43